Good Pharmaceutical can supply protease inhibitors for the treatment of HCV to patients in markets where they are not available at present, through locally compliant, “named patient” channels.



We offer full support in ensuring compliance with local regulations and logistics to ensure stable supply of medicines to patients in need.



Please contact us by clicking here.